Atlas Trials

A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

Clinical trial NCT05022758 · COMPLETED

Trial details

NCT number
NCT05022758
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Non-valvular Atrial Fibrillation (NVAF)
Start date
2021-10-06
Primary completion
2022-10-24
Enrollment
45000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.